- cafead Jan 18, 2023 at 11:12: PM
via Amgen is going all in on a three-indication collaboration with an Ann Arbor, MI biotech.
The California pharma has elected to move forward with all three autoimmune programs in its $240 million pact with EVOQ Therapeutics, the companies said Wednesday. EVOQ received an undisclosed milestone payment.
article source
The California pharma has elected to move forward with all three autoimmune programs in its $240 million pact with EVOQ Therapeutics, the companies said Wednesday. EVOQ received an undisclosed milestone payment.
article source